SOLENA MATERIALS LIMITED

Company number 13526395 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

SOLENA MATERIALS LIMITED - Analysis Report

Company Number: 13526395

Analysis Date: 2025-07-20 15:39 UTC

Financial Health Assessment for SOLENA MATERIALS LIMITED


1. Financial Health Score: B-

Explanation:
SOLENA MATERIALS LIMITED demonstrates a stable financial footing with strong shareholder equity and positive working capital. However, there are signs of liquidity tightening and accumulated losses which warrant caution. The company is not in distress but shows symptoms of needing careful cash flow management and profitability improvement to sustain long-term health.


2. Key Vital Signs

Metric 2024 Value (£) Interpretation
Current Assets 970,715 Healthy short-term resources but sharply down from prior year.
Cash 573,520 Positive cash balance but reduced significantly from £1.6M.
Debtors 397,195 Stable receivables, indicating consistent customer payments.
Current Liabilities 114,084 Relatively low short-term debts, manageable liabilities.
Net Current Assets 856,631 Positive working capital, indicating ability to cover short-term debts comfortably.
Fixed Assets (Tangible) 276,550 Substantial investment in physical assets, mostly plant and equipment.
Shareholders’ Funds 1,133,181 Equity remains positive but has dropped from prior year level.
Profit & Loss Reserves (1,966,833) Accumulated losses indicate ongoing investment or operational losses.

Vital Signs Interpretation:

  • The company’s current assets have declined sharply from £2M+ to under £1M, mainly due to a reduction in cash reserves, signaling tighter liquidity—a "weak pulse" in cash flow terms.
  • Positive net current assets indicate an ability to meet short-term obligations — a "stable heartbeat."
  • The large accumulated losses are a "chronic symptom," showing that the company has yet to achieve profitability, common for early-stage or high-investment ventures.
  • The tangible asset base remains solid, representing capital investments potentially supporting future growth.

3. Diagnosis

SOLENA MATERIALS LIMITED appears to be in a growth and development phase with significant investments in tangible assets and ongoing operational expenditures exceeding revenues (as indicated by accumulated losses). The company's liquidity has weakened over the past year, shown by a substantial decline in cash reserves, which could become a "symptom of distress" if not managed carefully.

The positive working capital shows the company has not yet encountered immediate solvency issues, but the decrease in net assets and shareholders’ funds signals a need to monitor capital structure closely. The directors’ statement on going concern suggests they believe the company can continue operating, but this depends on securing further funding or achieving operational profitability.

The industry classification in specialised design and man-made fibres aligns with a capital-intensive, innovation-driven business model, which often requires upfront investment and experiences delayed revenues.


4. Recommendations

  1. Cash Flow Management:
    Implement rigorous cash flow forecasting and control to prevent liquidity shortages. Consider negotiation of payment terms with suppliers and customers to smooth cash cycles.

  2. Profitability Focus:
    Develop a clear pathway to profitability by reviewing cost structures and pricing strategies. Explore revenue growth initiatives to convert the innovative product pipeline into sales.

  3. Capital Raising:
    Given accumulated losses and reduced cash, seek additional equity investments or alternative financing to strengthen the balance sheet and fund ongoing development.

  4. Asset Utilisation:
    Review fixed asset utilisation and consider whether any underused assets can be sold or better leveraged to generate income or reduce maintenance costs.

  5. Monitoring Financial KPIs:
    Track key ratios like current ratio, quick ratio, and operating margin monthly to detect early signs of financial strain.

  6. Governance and Reporting:
    Continue transparent financial reporting and maintain strong board oversight to ensure timely decision-making and compliance.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.